Diabetes Drug Metformin Cuts Long COVID Risk by 53%
Diabetes Drug Metformin Cuts Long COVID Risk by 53%
Diabetes Drug Metformin Cuts Long COVID Risk by 53%
Key points
اہم نکات
मुख्य बातें
- A common diabetes drug taken soon after a COVID infection may cut the risk of long COVID or death by more than half, a new study suggests.
- Researchers looked at health records from more than 21 million Americans and found patients prescribed metformin within six days of infection had a 53 percent lower risk over six months than patients given other drugs, with 4 percent affected compared with 8.5 percent.
- The study, published in the Journal of Medical Virology, backs up earlier trial results, though the researchers say the findings show an association and more work is needed.
- A common diabetes drug taken soon after a COVID infection may cut the risk of long COVID or death by more than half, a new study suggests.
- Researchers looked at health records from more than 21 million Americans and found patients prescribed metformin within six days of infection had a 53 percent lower risk over six months than patients given other drugs, with 4 percent affected compared with 8.5 percent.
- The study, published in the Journal of Medical Virology, backs up earlier trial results, though the researchers say the findings show an association and more work is needed.
- A common diabetes drug taken soon after a COVID infection may cut the risk of long COVID or death by more than half, a new study suggests.
- Researchers looked at health records from more than 21 million Americans and found patients prescribed metformin within six days of infection had a 53 percent lower risk over six months than patients given other drugs, with 4 percent affected compared with 8.5 percent.
- The study, published in the Journal of Medical Virology, backs up earlier trial results, though the researchers say the findings show an association and more work is needed.
A common diabetes drug taken soon after a COVID infection may cut the risk of long COVID or death by more than half, a new study suggests. Researchers looked at health records from more than 21 million Americans and found patients prescribed metformin within six days of infection had a 53 percent lower risk over six months than patients given other drugs, with 4 percent affected compared with 8.5 percent. The study, published in the Journal of Medical Virology, backs up earlier trial results, though the researchers say the findings show an association and more work is needed.
A common diabetes drug taken soon after a COVID infection may cut the risk of long COVID or death by more than half, a new study suggests. Researchers looked at health records from more than 21 million Americans and found patients prescribed metformin within six days of infection had a 53 percent lower risk over six months than patients given other drugs, with 4 percent affected compared with 8.5 percent. The study, published in the Journal of Medical Virology, backs up earlier trial results, though the researchers say the findings show an association and more work is needed.
A common diabetes drug taken soon after a COVID infection may cut the risk of long COVID or death by more than half, a new study suggests. Researchers looked at health records from more than 21 million Americans and found patients prescribed metformin within six days of infection had a 53 percent lower risk over six months than patients given other drugs, with 4 percent affected compared with 8.5 percent. The study, published in the Journal of Medical Virology, backs up earlier trial results, though the researchers say the findings show an association and more work is needed.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।